Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. (RXRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RXRX · as of Jun 8, 2026
Key Statistics
Explore Recursion Pharmaceuticals, Inc. Data
rxrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 40.0%
The RXRX analyst consensus is Hold, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $8.25, representing +148.49% upside from the current price of $3.32.
Competitors & Peers
rxrx competitorsRXRX
AGIO
BEAM
COGT
DNLI
ETNBStock Performance
Full HistoryAbout Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. operates as a biotechnology firm currently in its clinical development phase. The company's mission is to revolutionize drug discovery by decoding biological processes,…
what is recursion pharmaceuticals, inc. · rxrx stock overview · recursion pharmaceuticals, inc. company profile · who is recursion pharmaceuticals, inc. ceo · rxrx NASDAQ · recursion pharmaceuticals, inc. headquarters · recursion pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Recursion Pharmaceuticals, Inc. (RXRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 16, 2021. As of the latest trading session, RXRX stock price is $3.32, with a market capitalization of $1.5B. The stock has returned -38.42% over the past 12 months and -19.15% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Recursion Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $8.25. In fiscal year 2025, Recursion Pharmaceuticals, Inc. reported revenue of $74.7M and net income of -$644.8M. For detailed data — including Recursion Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Recursion Pharmaceuticals, Inc. (RXRX) stock price is $3.32. The stock is traded on NASDAQ under the ticker symbol RXRX. The 52-week range is $2.77 – $7.18.